Pro-oxidative and antioxidative controls and signaling modification of polyphenolic phytochemicals: contribution to health promotion and disease prevention?
Polyphenolic phytochemicals (PPs) have been extensively studied as potential nutriceuticals for maintenance of health and treatment of cancer, inflammation, and neurodegeneration. However, the reported beneficial outcomes are inconsistent. The biological activities of PPs have been attributed to their pro-oxidative and antioxidative actions and effects on signaling mechanisms and epigenomic modifications. These diversified properties were described or postulated on the basis of a variety of experimental studies using cell culture and animal models, even though most have not been replicated and results are not validated. This review attempts to give an overview of biological properties of PPs, based on the coherent results from relevant studies, and evaluate critically the experimental conditions and possible artifacts. Complicated molecular mechanisms and multitargeting genomic interactions of PPs are discussed, with a view that reasonable mechanistic propositions are usually obtained from well-designed in vivo studies.
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong in Hong Kong Eye Hospital , Kowloon, Hong Kong.
Kai On
KO
Chu
Sun-On
SO
Chan
Chi Pui
CP
Pang
Chi Chiu
CC
Wang
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D006293:Health Promotion; D006801:Humans; D016877:Oxidants / Q000494:pharmacology*; D010084:Oxidation-Reduction; D059808:Polyphenols / Q000494:pharmacology*; D011315:Preventive Medicine
D000975:Antioxidants; D016877:Oxidants; D059808:Polyphenols
antioxidation; epigenetic; phytochemical polyphenols; pro-oxidation; signaling